TG-0054: Clinical Trials

1 trial of TG-0054, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow TG-0054: new trials by email Literature Review of TG-0054 trials Research Report on TG-0054

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of TG-0054 With Single IV Doses Escalation in Healthy Volunteers
TG-0054 - Healthy
Phase 1CompletedGPCR Therapeutics, Inc.642008-04-012021-08-04

Sponsors

GPCR Therapeutics, Inc. (1)

Countries

United States (1)

Top investigators

Ronald Goldwater, M.D. (1)

Results publications

PMID 40156952